Open Access

Conservative in utero treatment of fetal dyshormonogenetic goiter with levothyroxine, a systematic literature review

  • Authors:
    • Dragos Nemescu
    • Ingrid Andrada Tanasa
    • Dana Liana Stoian
    • Dan Bogdan Navolan
    • Angela Elena Vinturache
  • View Affiliations

  • Published online on: May 26, 2020     https://doi.org/10.3892/etm.2020.8794
  • Pages: 2434-2438
  • Copyright: © Nemescu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Fetal goitrous hypothyroidism is a rare condition associated with important obstetrical, neonatal complications, and neurodevelopmental impairments. Prenatal treatment remains controversial, and the risk to benefit ratio must be accurately assessed and considered for individualized management. The objective of this review was to evaluate the feasibility, safety, and effectiveness of the conservative in utero treatment of fetal goitrous hypothyroidism. In total, 25 reports that met our inclusion criteria were selected and the management of 38 cases was analyzed. Prenatal diagnosis consisted mainly of ultrasonographic findings. Fetal thyroid status was assessed by cordocentesis. Prenatal treatment varied widely in terms of levothyroxine (LT4) route of administration, dosage, number of injections, and frequency. Although different regimens and routes of administration were proposed, they seem to have similar results regarding fetal goiter reduction and thyroid status at birth. At birth, most babies had hypothyroidism, but the long‑term follow‑up indicated a normal psycho‑neuromotor development. Our data confirm the feasibility of conservative treatment with LT4 for fetal goitrous hypothyroidism. Further studies are needed to determine the optimal management of this disorder.

Related Articles

Journal Cover

September-2020
Volume 20 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nemescu D, Tanasa IA, Stoian DL, Navolan DB and Vinturache AE: Conservative in utero treatment of fetal dyshormonogenetic goiter with levothyroxine, a systematic literature review. Exp Ther Med 20: 2434-2438, 2020
APA
Nemescu, D., Tanasa, I.A., Stoian, D.L., Navolan, D.B., & Vinturache, A.E. (2020). Conservative in utero treatment of fetal dyshormonogenetic goiter with levothyroxine, a systematic literature review. Experimental and Therapeutic Medicine, 20, 2434-2438. https://doi.org/10.3892/etm.2020.8794
MLA
Nemescu, D., Tanasa, I. A., Stoian, D. L., Navolan, D. B., Vinturache, A. E."Conservative in utero treatment of fetal dyshormonogenetic goiter with levothyroxine, a systematic literature review". Experimental and Therapeutic Medicine 20.3 (2020): 2434-2438.
Chicago
Nemescu, D., Tanasa, I. A., Stoian, D. L., Navolan, D. B., Vinturache, A. E."Conservative in utero treatment of fetal dyshormonogenetic goiter with levothyroxine, a systematic literature review". Experimental and Therapeutic Medicine 20, no. 3 (2020): 2434-2438. https://doi.org/10.3892/etm.2020.8794